[1]
Safarinejad, M.R. 2015. Re: Minimally Invasive Therapy Using Intralesional OnabotulinumtoxinA in Peyronie’s Disease. Urology Journal. 12, 2 (Apr. 2015), 2111–2114. DOI:https://doi.org/10.22037/uj.v12i2.3040.